In 2016, Kenya’s Ministry of Health updated its national HIV guidelines to provide guidance on the use of antiretrovirals to treat and prevent HIV. To inform implementation and resource mobilization, the National AIDS and STI Control Programme, the National AIDS Control Council, and HP+ jointly conducted an assessment on the costing implications of implementing the new guidelines. The study considered two costing scenarios—one based on achievement of UNAIDS’ 90-90-90 targets and another based on full adoption of the new guidelines. The results show that as more people living with HIV are enrolled in treatment programs, costs will increase under both scenarios, with commodities remaining as the largest cost driver. Kenya will need to mobilize additional resources for HIV treatment to fully implement the new guidelines.
See the full report and our brief, outlining the total cost for both scenarios, cost drivers, and implications and recommendations for scale-up.
Ministry of Health. 2017. Costing the Implementation of the 2016 HIV Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV in Kenya. Government of Kenya. USAID DEC: PA-00T-PQN
English PDF 811.6 kbMay 2019
Health Policy Plus and Kenya Ministry of Health. 2018. How Much Will It Cost for Kenya to Achieve National Targets in HIV Care by 2020? Washington, DC: Palladium, Health Policy Plus. USAID DEC: PA-00T-8VF
English PDF 342.7 kbJuly 2018
Information presented on this website is considered public information and may be distributed or copied freely unless identified as being subject to copyright protection.